Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
GLP-1R activation by retatrutide promotes glucose-dependent insulin secretion, suppresses glucagon during hyperglycemia, delays gastric emptying, and reduces appetite via CNS signaling
Inflammatory bowel disease represents the most advanced clinical target, with at least one Phase II trial having examined a BPC-157-derivative compound (PL 14736) for ulcerative colitis, showing preliminary evidence of mucosal healing in human patients
See our complete guide to peptides for broader context on peptide research protocols
It's specifically designed for reconstituting and diluting medications that will be stored and used over a period of days to weeks, where the preservative property of benzyl alcohol extends the usable life of the reconstituted solution
US$ 23.05
US$ 24.61
US$ 29.30
US$ 24.09
